Follow us on:

Linkedin Facebook

Oncimmune to present at the Solebury Trout European Biotech Investor Day

Oncimmune Holdings Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Oncimmune Holdings PLC (LON:ONC), a Leading Global Immunodiagnostics Group, will be presenting at the Solebury Trout European Biotech Investor Day today, Thursday 1st August 2019, at 11.30 am EDT (16:30 BST) in New York, USA. A live webcast will be available to watch the presentation under the IR section of Oncimmune’s website and will be available for six months at: Oncimmune Holdings Plc – Solebury Trout European Investor meetings 2019

Adam Hill, Chief Executive Officer of Oncimmune, will be presenting an overview of the Company and will be available to take questions following the event.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

    Latest Company News

    oncimmune holdings

    Oncimmune Holdings receives Queen’s Award for Enterprise in Innovation 2022

    oncimmune holdings

    Oncimmune Holdings report two further ImmunoINSIGHTS contracts signed

    oncimmune holdings

    Oncimmune Holdings follow-on contract signed with leading US medical research organisation

    oncimmune holdings

    Oncimmune ImmunoINSIGHTS contract signed with leading top 10 global pharmaceutical company

    oncimmune holdings

    Oncimmune go-to-market partnership with Synexa Life Sciences BV

    Growth

    Oncimmune’s growing pipeline supporting improved performance and realisation of value

      Latest interviews

      View all interviews 

      Company Presentations

      View all Company Presentations

      Brokers Talk

      View all Broker Talk

      FTSE 100 News

      Search

      Search

      Green News

      View all Sustainable sectors, Plcs and news  

      Q&A's

      View all Question and Answers

      Funds

      View all Funds, Market Insights and news

      UK Broker Ratings

      Hardman & Co

      Don't Miss Our News Alerts

      Subscribe Free

      Find us on:

      Linkedin Facebook

      Useful links

      Disclaimer

      You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

      © 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.